Hypothesis

During sleep, the glymphatic system does more than clear soluble waste; it creates rhythmic extracellular ATP fluctuations that directly modulate microglial P2Y12 receptor activity, biasing the complement‑mediated tagging of synapses for elimination or preservation. In this model, sleep‑driven interstitial fluid flow acts as a signaling conduit that translates metabolic state into synaptic triage decisions, linking AQP4‑dependent glymphatic clearance to activity‑dependent synaptopathy.

Mechanistic Rationale

1. Glymphatic‑driven ATP waves – Astrocytic calcium transients, amplified by the expanded interstitial space during slow‑wave sleep, trigger vesicular ATP release into the perivascular CSF‑ISF exchange pathway (1). The resulting extracellular ATP oscillates in phase with delta‑band CSF pulsations.
2. Microglial P2Y12 as a flow sensor – Microglial processes express high levels of P2Y12 receptors, which bind ATP/ADP and drive chemotactic motility toward sites of nucleotide release (2). When ATP peaks during sleep, P2Y12 activation promotes microglial surveillance of synapses that have released low levels of activity‑dependent ATP (i.e., weakly active synapses).
3. Complement tagging bias – Low‑activity synapses release less neuronal ATP, resulting in a relatively higher extracellular ADP/ATP ratio that favors P2Y12‑mediated microglial process extension and subsequent C1q deposition (3). Conversely, highly active synapses maintain elevated ATP, overwhelming P2Y12 signaling and protecting them from complement tagging via adenosine‑A2A receptor–mediated anti‑inflammatory pathways.
4. AQP4 dependence – Loss of AQP4 polarity dampens the interstitial ATP wave amplitude, reducing microglial P2Y12 activation and leading to indiscriminate synaptic tagging or failure to prune low‑effort connections (4).

Predictions

• Sleep deprivation will flatten extracellular ATP oscillations, decreasing P2Y12‑dependent microglial process motility and causing either (a) reduced C1q tagging of low‑activity synapses (synaptic retention) or (b) ectopic tagging of high‑activity synapses due to loss of differential signaling.
• Genetic ablation of microglial P2Y12 will uncouple sleep‑linked synaptic remodeling from glymphatic flux, producing normal waste clearance but aberrant synapse density regardless of sleep quality.
• Pharmacological enhancement of slow‑wave sleep (e.g., via GABA_A agonists) will amplify ATP waves, increase P2Y12‑mediated microglial contacts with low‑activity synapses, and accelerate their elimination in tauopathy models.

Experimental Approach

1. In vivo ATP imaging – Use genetically encoded ATP sensors (ATeam) in mouse cortex to compare ATP dynamics across wake, NREM, and REM states, with and without AQP4 knockdown (AAV‑shAQP4).
2. Microglial P2Y12 manipulation – Cross Cx3cr1‑CreER mice with P2Y12^fl/fl for inducible knockout; assess microglial process motility (two‑photon imaging) and synaptic C1q deposition (immunohistochemistry) after sleep deprivation vs. sleep enhancement.
3. Synaptic outcome – Quantify excitatory (PSD‑95) and inhibitory (gephyrin) puncta density in layer II/III cortex; correlate with behavioral memory tasks.
4. Rescue tests – Apply exogenous ATPγS via CSF infusion during sleep deprivation to restore P2Y12 signaling and evaluate whether synaptic tagging patterns normalize.

Potential Implications

If validated, this hypothesis reframes sleep not merely as a clearance window but as a active regulatory circuit that couples fluid dynamics to immune‑synaptic surveillance. It offers a mechanistic link between sleep disturbances, microglial dysfunction, and the synaptic dysconnectivity observed in Alzheimer’s disease, traumatic brain injury, and psychiatric disorders, suggesting that targeting the ATP‑P2Y12 axis could preserve synaptic integrity even when glymphatic flow is compromised.